The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne ...

The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the ...

By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide[d] no premium to the closing price per share on ... holder of ...

On Monday, Citi reiterated a Neutral rating on 23andMe Holding Co (NASDAQ:ME) stock with a price target of $0.42. The firm's commentary followed the presentation of additional trial data by ...

In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference ...

On Tuesday, the independent directors of the Board of 23andMe Holding Co. (NASDAQ:ME) sent a letter to Anne Wojcicki, Chief ...

The stock of 23andMe has a consensus Moderate Buy rating based on the views of two Wall Street analysts. One analyst rates the stock a Buy and the other rates it a Hold. There are no Sell ratings ...

On Friday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.34 which represents a slight increase of $0.01 or 3.03% from the prior close of $0.33. The stock opened at $0.33 and ...

Citi analyst David Lebovitz maintained a Hold rating on 23andMe Holding (ME – Research Report) yesterday and set a price target of $0.42.

After suffering a data breach last year, seven board members have now resigned from 23andMe, hindering the CEO's plan to take ...